MNNGF (Baijin Life Science Holdings) Market Cap : $60.01 Mil (As of Mar. 28, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Baijin Life Science Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Baijin Life Science Holdings's share price for the quarter that ended in Sep. 2024 was $0.07. Baijin Life Science Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 679.25 Mil. Therefore, Baijin Life Science Holdings's market cap for the quarter that ended in Sep. 2024 was $47.55 Mil.

Baijin Life Science Holdings's quarterly market cap declined from Sep. 2023 ($51.14 Mil) to Mar. 2024 ($50.94 Mil) and declined from Mar. 2024 ($50.94 Mil) to Sep. 2024 ($47.55 Mil).

Baijin Life Science Holdings's annual market cap increased from Mar. 2022 ($3.70 Mil) to Mar. 2023 ($38.36 Mil) and increased from Mar. 2023 ($38.36 Mil) to Mar. 2024 ($50.94 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Baijin Life Science Holdings's Enterprise Value for Today is $67.27 Mil.

Baijin Life Science Holdings Market Cap Historical Data

The historical data trend for Baijin Life Science Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings Market Cap Chart

Baijin Life Science Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Market Cap

Get a 7-Day Free Trial

1.95

3.64

3.70

38.36

50.94

Baijin Life Science Holdings Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Market Cap	Get a 7-Day Free Trial															38.36	38.36	51.14	50.94	47.55

Competitive Comparison of Baijin Life Science Holdings's Market Cap

For the Luxury Goods subindustry, Baijin Life Science Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baijin Life Science Holdings's Market Cap Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Market Cap falls into.

Save Embed

;

Save Embed

;

Baijin Life Science Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Baijin Life Science Holdings's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )	=	Share Price (A: Mar. 2024 )	*	Shares Outstanding (EOP) (A: Mar. 2024 )
	=	$0.075	*	679.252
	=	$50.94

Baijin Life Science Holdings's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$0.07	*	679.252
	=	$47.55

Baijin Life Science Holdings (OTCPK:MNNGF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Baijin Life Science Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (OTCPK:MNNGF) » Definitions » Market Cap

Traded in Other Exchanges

01466:Hong Kong

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.